Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin in Frontotemporal Dementia
NCT01937013Phase 2Completed
- Start
- Sep 2013
- Primary completion
- Dec 2017
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin nasal spray in frontotemporal dementia (FTD). Started Sep 2013; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
frontotemporal dementia (FTD)
Beyond the preview
Go deeper on NCT01937013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01937013.